# The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients

> **NCT04321616** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Oslo University Hospital** · enrollment: 700 (estimated)

## Conditions studied

- SARS-CoV Infection
- COVID 19
- Acute Respiratory Distress Syndrome ARDS

## Interventions

- **DRUG:** Hydroxychloroquine
- **DRUG:** Remdesivir
- **OTHER:** (Standard of Care) SoC

## Key facts

- **NCT ID:** NCT04321616
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-28
- **Primary completion:** 2020-08
- **Final completion:** 2020-11
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2020-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04321616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04321616, "The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04321616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*